Record Information
Version2.0
StatusDetected and Quantified
Creation Date2021-05-15 03:21:13 UTC
Update Date2025-10-07 16:05:52 UTC
Metabolite IDMMDBc0011498
Metabolite Identification
Common NameGERI-BP001
DescriptionGERI-BP001 is a metabolite classified as a new inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT) derived from the fungus Aspergillus fumigatus F37. This compound was isolated through a series of chemical processes including acetone extraction, ethyl acetate extraction, silica gel column chromatography, and reverse phase high-performance liquid chromatography (HPLC) (PMID:7592016 ). The biological activity of GERI-BP001 has been demonstrated in enzyme assays, where it effectively inhibits ACAT activity in rat liver microsomes, achieving 50% inhibition at concentrations of 42, 94, and 40 µM for its variants M, A, and B, respectively (PMID:7592016 ). The significance of GERI-BP001 in cholesterol metabolism highlights its potential therapeutic applications in managing conditions related to cholesterol dysregulation. Further studies may elucidate its mechanism of action and broader biological implications, underscoring the importance of natural products in drug discovery and development.
Structure
SynonymsNot Available
Molecular FormulaC27H33NO5
Average Mass451.563
Monoisotopic Mass451.235873167
IUPAC Name(5aR,7aR,9S,11aS,11bR)-5a,8,8,11a-tetramethyl-1-oxo-3-(pyridin-3-yl)-1,5a,6,7,7a,8,9,10,11,11a,11b,12-dodecahydro-2,5-dioxatetraphen-9-yl acetate
Traditional Name(5aR,7aR,9S,11aS,11bR)-5a,8,8,11a-tetramethyl-1-oxo-3-(pyridin-3-yl)-6,7,7a,9,10,11,11b,12-octahydro-2,5-dioxatetraphen-9-yl acetate
CAS Registry NumberNot Available
SMILES
[H][C@@]1(CC[C@@]2(C)[C@@]([H])(CC[C@@]3(C)OC4=C(C[C@]23[H])C(=O)OC(=C4)C2=CN=CC=C2)C1(C)C)OC(C)=O
InChI Identifier
InChI=1S/C27H33NO5/c1-16(29)31-23-9-10-26(4)21(25(23,2)3)8-11-27(5)22(26)13-18-20(33-27)14-19(32-24(18)30)17-7-6-12-28-15-17/h6-7,12,14-15,21-23H,8-11,13H2,1-5H3/t21-,22+,23-,26-,27+/m0/s1
InChI KeySDKNSMCWHHTGRG-KCXTWHPGSA-N